Skip to content

Everus Construction

US · ECG #1890 by market cap Listed 1970
125.26 -7.48 -5.64%
Live - 5344 symbols - heartbeat 278s ago · 2026-10-08 07:31
Pre-market 124.99 -0.22%
After-hours 125.15 -0.09%
Market cap
6.40B
P/B
8.27
EPS
3.95
Reader sentiment Are you bullish or bearish on ECG?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Mixed / stable
  • The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
86.62% +0.06pp
Institutions
615 -1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund72.81%
Hedge Fund6.85%
Public Company2.38%
Private Company1.91%
Government Pension Fund1.65%
Family Office/Trust0.52%
Individual/Insider0.31%
Insurance Company0.29%
Other13.19%

Top holders as of 2026-06-30

BlackRock 12.91% · 6.59M sh
Vanguard Portfolio Management, LLC 5.17% · 2.64M sh
Vanguard Capital Management, LLC 5.16% · 2.63M sh
Capital Research 4.17% · 2.13M sh
State Street Global Advisors 3.32% · 1.69M sh
Geode Capital Management, LLC 2.85% · 1.46M sh
Invesco Ltd. 2.38% · 1.22M sh
Wasatch Advisors LP 2.34% · 1.20M sh
Dimensional Fund Advisors 2.05% · 1.05M sh
First Trust Advisors L.P. 1.90% · 967.69K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 40 buys · 10 sells

NameRoleStake
Jeffrey Thiede President and Chief Executive Officer 0.13%
Edward Ryan Director 0.04%
David Sparby Director 0.04%
Thomas Nosbusch Chief Operating Officer 0.03%
Dale Rosenthal Chairperson 0.02%
Jon Hunke Vice President 0.02%
Michael Della Rocca Director 0.01%
Timothy Sznewajs Vice President of Corporate Development & Strategy 0.01%
Paul Sanderson VP, Chief Legal Officer & Secretary 0.01%
Maximillian Marcy Chief Financial Officer 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-30 Dale Rosenthal Chairperson Other Acquisition +203 $128.99
2026-08-30 Edward Ryan Director Other Acquisition +121 $128.99
2026-08-16 David Sparby Director Open Market Acquisition +1,000 $144.95
2026-08-06 Paul Sanderson VP, Chief Legal Officer & Secretary Open Market Disposition -3,300 $136.69
2026-05-28 Dale Rosenthal Chairperson Other Acquisition +169 $154.72
2026-05-28 Edward Ryan Director Other Acquisition +100 $154.72
2026-05-21 Timothy Sznewajs Vice President of Corporate Development & Strategy Sale to Issuer -1,361 $148.65
2026-05-11 David Sparby Director Other Acquisition +1,015 --
2026-05-11 Betty Wynn Director Other Acquisition +1,015 --
2026-05-11 Dale Rosenthal Chairperson Other Acquisition +1,184 --
2026-05-11 Edward Ryan Director Other Acquisition +1,015 --
2026-05-11 Michael Della Rocca Director Other Acquisition +1,015 --
2026-05-11 Clark Wood Director Other Acquisition +1,015 --
2026-05-11 Helena Hernandez Director Other Acquisition +1,015 --
2026-02-26 Dale Rosenthal Chairperson Other Acquisition +125 $104.90
2026-02-26 Timothy Sznewajs Vice President of Corporate Development & Strategy Sale to Issuer -303 $120.87
2026-02-26 Timothy Sznewajs Vice President of Corporate Development & Strategy Other Acquisition +1,424 --
2026-02-26 Jeffrey Thiede President and Chief Executive Officer Sale to Issuer -11,997 $120.87
2026-02-26 Jeffrey Thiede President and Chief Executive Officer Other Acquisition +12,011 --
2026-02-26 Maximillian Marcy Chief Financial Officer Sale to Issuer -572 $120.87

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:31:19 · For reference only, not investment advice and not tailored to your situation.